Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
20.61
+0.81 (4.09%)
At close: Jan 2, 2025, 4:00 PM
20.05
-0.56 (-2.72%)
After-hours: Jan 2, 2025, 7:22 PM EST
Mesoblast Market Cap
Mesoblast has a market cap or net worth of $2.37 billion as of January 2, 2025. Its market cap has increased by 1,261.22% in one year.
Market Cap
2.37B
Enterprise Value
2.42B
1-Year Change
1,261.22%
Ranking
Category
Stock Price
$20.61
Market Cap Chart
Since November 13, 2015, Mesoblast's market cap has increased from $593.20M to $2.37B, an increase of 299.74%. That is a compound annual growth rate of 16.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2024 | 2.26B | 1,162.26% |
| Dec 29, 2023 | 179.10M | -58.22% |
| Dec 30, 2022 | 428.70M | -31.15% |
| Dec 31, 2021 | 622.70M | -37.40% |
| Dec 31, 2020 | 994.70M | 35.19% |
| Dec 31, 2019 | 735.80M | 84.92% |
| Dec 31, 2018 | 397.90M | -27.59% |
| Dec 29, 2017 | 549.50M | 34.55% |
| Dec 30, 2016 | 408.40M | -12.21% |
| Dec 31, 2015 | 465.20M | -21.58% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 695.13B |
| UnitedHealth Group | 465.54B |
| Novo Nordisk | 384.34B |
| Johnson & Johnson | 348.19B |
| AbbVie | 314.02B |
| Merck & Co. | 251.65B |
| AstraZeneca | 203.17B |
| Thermo Fisher Scientific | 198.99B |